185 related articles for article (PubMed ID: 25755998)
1. Capsule shell material impacts the in vitro disintegration and dissolution behaviour of a green tea extract.
Glube N; Moos Lv; Duchateau G
Results Pharma Sci; 2013; 3():1-6. PubMed ID: 25755998
[TBL] [Abstract][Full Text] [Related]
2. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.
Oketch-Rabah HA; Roe AL; Rider CV; Bonkovsky HL; Giancaspro GI; Navarro V; Paine MF; Betz JM; Marles RJ; Casper S; Gurley B; Jordan SA; He K; Kapoor MP; Rao TP; Sherker AH; Fontana RJ; Rossi S; Vuppalanchi R; Seeff LB; Stolz A; Ahmad J; Koh C; Serrano J; Low Dog T; Ko R
Toxicol Rep; 2020; 7():386-402. PubMed ID: 32140423
[TBL] [Abstract][Full Text] [Related]
3. Disintegration and Dissolution Testing of Green Tea Dietary Supplements: Application and Evaluation of United States Pharmacopeial Standards.
Gusev PA; Andrews KW; Savarala S; Tey PT; Han F; Oh L; Pehrsson PR; Dwyer JT; Betz JM; Kuszak AJ; Costello R; Saldanha LG
J Pharm Sci; 2020 Jun; 109(6):1933-1942. PubMed ID: 32081719
[TBL] [Abstract][Full Text] [Related]
4. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
Vardakou M; Mercuri A; Naylor TA; Rizzo D; Butler JM; Connolly PC; Wickham MS; Faulks RM
Int J Pharm; 2011 Oct; 419(1-2):192-9. PubMed ID: 21843611
[TBL] [Abstract][Full Text] [Related]
5. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
Honkanen O; Laaksonen P; Marvola J; Eerikäinen S; Tuominen R; Marvola M
Eur J Pharm Sci; 2002 Jun; 15(5):479-88. PubMed ID: 12036724
[TBL] [Abstract][Full Text] [Related]
7. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
8. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
[TBL] [Abstract][Full Text] [Related]
9. Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG).
Hu J; Zhou D; Chen Y
J Agric Food Chem; 2009 Feb; 57(4):1349-53. PubMed ID: 19182914
[TBL] [Abstract][Full Text] [Related]
10. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
Ku MS; Lu Q; Li W; Chen Y
Int J Pharm; 2011 Sep; 416(1):16-24. PubMed ID: 21356291
[TBL] [Abstract][Full Text] [Related]
11. Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in Mice.
Oyanna VO; Bechtold BJ; Lynch KD; Ridge Call M; Graf TN; Oberlies NH; Clarke JD
Pharm Res; 2024 Mar; 41(3):557-566. PubMed ID: 38302834
[TBL] [Abstract][Full Text] [Related]
12. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
13. Dissolution Profile of Mefenamic Acid Solid Dosage Forms in Two Compendial and Biorelevant (FaSSIF) Media.
Nurhikmah W; Sumirtapura YC; Pamudji JS
Sci Pharm; 2016; 84(1):181-90. PubMed ID: 27110508
[TBL] [Abstract][Full Text] [Related]
14. The shell dissolution of various empty hard capsules.
Chiwele I; Jones BE; Podczeck F
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
[TBL] [Abstract][Full Text] [Related]
15. The in vitro dissolution of theophylline from different types of hard shell capsules.
Podczeck F; Jones BE
Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
[TBL] [Abstract][Full Text] [Related]
17. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
Pandit AP; Joshi SR; Dalal PS; Patole VC
BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
[TBL] [Abstract][Full Text] [Related]
18. Enteric Hard Capsules for Targeting the Small Intestine: Positive Correlation between In Vitro Disintegration and Dissolution Times.
Fu M; Al-Gousous J; Blechar JA; Langguth P
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028731
[TBL] [Abstract][Full Text] [Related]
19. In vitro transdermal delivery of the major catechins and caffeine from extract of Camellia sinensis.
Batchelder RJ; Calder RJ; Thomas CP; Heard CM
Int J Pharm; 2004 Sep; 283(1-2):45-51. PubMed ID: 15363500
[TBL] [Abstract][Full Text] [Related]
20. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]